Edition:
United Kingdom

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

8.91USD
20 Apr 2018
Change (% chg)

$0.16 (+1.83%)
Prev Close
$8.75
Open
$8.72
Day's High
$9.00
Day's Low
$8.55
Volume
50,199
Avg. Vol
59,258
52-wk High
$23.68
52-wk Low
$7.85

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.25 December 23 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 3 3 2
(2) OUTPERFORM 1 2 2 2
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.40 1.40 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 3 8.97 10.10 8.30 --
Quarter Ending Sep-18 3 7.17 8.30 5.10 --
Year Ending Dec-18 4 35.85 54.90 22.30 66.67
Year Ending Dec-19 4 18.58 43.80 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 3 -0.25 -0.09 -0.39 --
Quarter Ending Sep-18 3 -0.40 -0.12 -0.57 --
Year Ending Dec-18 4 -1.33 -0.61 -2.03 0.23
Year Ending Dec-19 4 -2.07 -0.98 -3.50 -4.51

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 8.88 11.28 2.41 27.12
Quarter Ending Sep-17 3.07 8.78 5.71 186.33
Quarter Ending Jun-17 2.00 0.00 2.00 100.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 8.97 8.97 8.97 8.50 --
Quarter Ending Sep-18 7.17 7.17 7.17 8.10 --
Year Ending Dec-18 35.85 35.85 39.67 40.83 66.67
Year Ending Dec-19 18.58 18.58 22.11 16.31 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 1
Earnings